Nuclear Medicine in Times of COVID-19: How Radiopharmaceuticals Could Help to Fight the Current and Future Pandemics
The emergence and global spread of COVID-19, an infectious disease caused by the novel coronavirus SARS-CoV-2, has resulted in a continuing pandemic threat to global health. Nuclear medicine techniques can be used for functional imaging of (patho)physiological processes at the cellular or molecular...
Saved in:
Main Authors: | Felix Neumaier (Author), Boris D. Zlatopolskiy (Author), Bernd Neumaier (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2020-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Drug Penetration into the Central Nervous System: Pharmacokinetic Concepts and In Vitro Model Systems
by: Felix Neumaier, et al.
Published: (2021) -
Guidance for nuclear medicine staff on radiopharmaceuticals drug interaction
by: Ralph Santos-Oliveira
Published: (2009) -
Targets, Tracers and Translation - Novel Radiopharmaceuticals Boost Nuclear Medicine
by: Reischl, Gerald
Published: (2019) -
Convenient Preparation of 18F-Labeled Peptide Probes for Potential Claudin-4 PET Imaging
by: Lucia Feni, et al.
Published: (2017) -
Innovations in Nuclear Medicine Imaging for Reactive Oxygen Species: Applications and Radiopharmaceuticals
by: Joo Yeon Park, et al.
Published: (2024)